Abstract
Objectives
To study the complications and consequences including maternal morbidity and mortality following indiscriminate self-consumption of abortion pills reporting to a tertiary care center.
Methodology
This is an observational study conducted at Vanivilas hospital between January 2012 to December 2013 for 24 months. After applying inclusion and exclusion criteria, 104 women were studied with respect to period of gestation, parity, clinical features at presentation and management in the institution. An analysis of maternal morbidity and mortality was done with respect to surgical interventions, ICU admissions, need for blood transfusions and maternal deaths.
Observations and results
In this study, there were 75 (72.2 %) cases of incomplete abortion, 10 (9.6 %) cases of missed abortion, 2 (1.9 %) cases of ruptured ectopic and 2 (1.9 %) cases of rupture uterus. Seventy-eight (75 %) cases received blood transfusion, 7 (6.7 %) were admitted to ICU, and 2 (1.9 %) developed acute kidney injury. There were 2 (1.9 %) maternal deaths in the study group.
Conclusion
This study shows urgent need for legislation and restriction of drugs used for medical termination of pregnancy. Drugs should be made available via health care facilities under supervision to reduce maternal mortality and morbidity due to indiscriminate use of these pills.
Similar content being viewed by others
References
Cunningham FG, Leveno KJ, Bloom SL, Haulh JC, Gilstrap LC, Wenstrom KD, editors. Abortion. Williams Textbook of Obstetrics, 24th ed. New York: McGraw-Hill; 2014. pp. 215–235.
Chaudhari SK. Pregnancy termination. In: Practice of Fertility Control a Comprehensive Manual, 7th ed. New Delhi: Elsevier; pp 237–263.
International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens and Service Delivery. Frequently asked clinical questions about medical abortion. Geneva: World Health Organization; 2006. ISBN 92-4-159484-5.
Ellertson C, Waldman SN. The Mifepristone–Misoprostol regimen for early medical abortion. Curr Women Health Rep. 2001;1:184–90.
Thaker RV, Deliwala KJ, Shah PT. Self medication of abortion pill: women’s Health in Jeopardy. NHL J Med Sci. 2014; 3(1):26–31.
http://www.mohfw.nic.in/index1.php?sublinkid=3613&level=3&lid=2597&lang=1.
Kapur K, Joneja GS, Biswas M. Medical abortion—an alternative to surgical abortion. MJAFI. 2006;62:351–3.
Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. J Am Med Womens Assoc. 2000;55(3 suppl):191–4.
http://www.fogsi.org/index.php?option=com_content&view=article&id=97&Itemid=16.
Bajwa SK, Bajwa SJS, Ghai GK, Singh N, Singh A, Goraya SPS. Medical abortion: is it a blessing or curse for the developing nations? Sri Lanka J Obstet Gynaecol. 2011;33(3):84–90.
Tran NT, Jang MC, Choe YS, et al. Feasibility, efficacy, safety and acceptability of Mifepristone–Misoprostol for medical abortion in the Democratic People’s Republic of Korea. Int J Gynecol Obstet. 2010;109(3):209–12.
Debnath J, Gulati S, Mathur A, et al. Ectopic pregnancy in the era of medical abortion: are we ready for it? Spectrum of sonographic findings and our experience in a tertiary care service hospital of India. J Obstet Gynecol India. 2013;66(6):388–93.
Hausknecht R. Mifepristone and Misoprostol for early medical abortion: 18 months experience in United States. Contraception. 2003;67:463–5.
Deshpande S, Yelikar K, Deshmukh A, et al. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women <49 days versus 50–63 days of amenorrhoea. J Obstet Gynecol India. 2010;60(5):403–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Sarojini, Dr. T.R. Ashakiran, Dr. B.T. Bhanu, and Dr. Radhika declare that we do not have any conflict of interest.
Ethical Approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Ethical committee clearance from the institution was obtained.
Informed Consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Dr. Sarojini is an Assistant Professor in Department of OBG, BMCRI, Bangalore; Dr. T.R. Ashakiran is an Assistant Professor in Department of OBG, BMCRI, Bangalore; Dr. B.T. Bhanu is an ICMO in Department of OBG, BMCRI, Bangalore; Dr. Radhika is an Assistant Professor in Department of OBG, BMCRI, Bangalore.
Rights and permissions
About this article
Cite this article
Sarojini, Ashakiran, T.R., Bhanu, B.T. et al. Over-the-counter MTP Pills and Its Impact on Women’s Health. J Obstet Gynecol India 67, 37–41 (2017). https://doi.org/10.1007/s13224-016-0916-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-016-0916-9